C
Citius Pharmaceuticals
CTXR
0.90610
USD
-0.0005
(-0.06%)
مغلق
حجم التداول
15,228
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
67,573,230
العنوان: Citius Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for thetreatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.